Skin News and Research

RSS

NACC recommendations address established pain therapies and preview potential future advances

Recommendations of the Neuromodulation Appropriateness Consensus Committee (NACC), announced at the 11th World Congress of the International Neuromodulation Society (INS), address established therapies and preview emerging and potential future advances.

13 Jun 2013

PRISM Pharma announces closing of $15 million Series C financing

PRISM Pharma Co., Ltd., a drug discovery company focused on developing small molecule technologies that modulate protein-protein interactions, today announced the close of an approximately $15 million (approximately ¥1.4 billion) Series C financing.

13 Jun 2013

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

Although several chemotherapy treatments are now administered by the oral route (targeted chemotherapy), most chemotherapy treatments (cytotoxics) are administered by the intravenous route.

13 Jun 2013

More pleasant method for measuring blood pressure

The consequences of high blood pressure are one of the most common causes of death worldwide. Despite this, according to the World Health Organization WHO, fewer than one in two of those affected measures their blood pressure regularly.

13 Jun 2013

New study shows treatment with brodalumab demonstrates clinical response in subjects with PsA

A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that treatment with brodalumab demonstrates significant clinical response and an acceptable safety profile in subjects with psoriatic arthritis.

13 Jun 2013

Tips for preventing skin cancer

Skin cancer is the most common form of cancer diagnosed in the United States, with one in five Americans expected to develop a form of skin cancer in their lifetime. Fortunately, there are simple steps people can take to reduce their skin cancer risk.

12 Jun 2013

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Before we talk about p53, it is important to understand why cancer cells are a problem for the body. Cancer cells multiply recklessly, refuse to die and blithely metastasize to set up shop in places where they don’t belong.

12 Jun 2013

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Neuromodulators have joined together in the Neuromodulation Appropriateness Consensus Committee (NACC) to provide the first coordinated set of recommendations about patient selection and appropriateness for implantation of "digital drugs" to manage chronic pain.

12 Jun 2013

Mentor announces availability of CPX4 Tissue Expander in EMEA markets

Following FDA approval for the US market in April, Mentor, leading global manufacturer of the highest quality breast implants is proud to announce the availability of the CPX4 Tissue Expander in the EMEA markets from June 12th 2013.

12 Jun 2013

Hebrew University student develops drug formulations to treat illnesses through skin applications

New, more efficient drug formulations designed to treat illnesses through skin applications -- thus avoiding serious side effects associated with oral drug-taking -- have been developed by a student at the Hebrew University of Jerusalem.

12 Jun 2013

TSRI scientists identify key triggers of cancer-blocking mechanism in cells

Scientists at The Scripps Research Institute have identified key triggers of an important cancer-blocking mechanism in cells.

12 Jun 2013

Telemedicine: A way to decrease patient wait times in ED

Emergency department overcrowding has been a major issue nationally for 20 years and continues to increase in severity. To address this issue, a pilot study has been launched at UC San Diego Health System's ED to use telemedicine as a way to help address crowding and decrease patient wait times.

12 Jun 2013

Studies demonstrate that combined therapy could destroy drug-resistant cells within melanoma tumor

Advanced metastatic melanoma is a disease that has proven difficult to eradicate. Despite the success of melanoma-targeting drugs, tumors inevitably become drug resistant and return, more aggressive than before. In the current issue of the journal Cancer Cell, however, researchers at The Wistar Institute describe how they increase the effectiveness of anti-melanoma drugs by combining anticancer therapies with diabetes drugs.

12 Jun 2013

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Men's Health Network and Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, have announced the launch of a new health awareness program called "Ask About the Curve" to provide information about Peyronie's disease and to help empower men to have meaningful discussions about their condition with their partner and their healthcare provider.

11 Jun 2013

Brain circuits involved in compulsive behavior reveal a surprising connection with obesity

What started as an experiment to probe brain circuits involved in compulsive behavior has revealed a surprising connection with obesity.

11 Jun 2013

OncoSec Medical signs Sponsored Research Agreement with ODU for melanoma study

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, signed a Sponsored Research Agreement with Old Dominion University and the Frank Reidy Research Center for Bioelectrics.

11 Jun 2013

New study explores effects of growth hormone on the skin

It seems everyone's talking about human growth hormone these days. CNN, Fox News, The Today Show, The Dr. Oz Show, Shape magazine… even Vanity Fair have all done features on hGH. Many of Hollywood's "elite" have been visiting some of the most expensive clinics in the world for controversial hGH therapy. Why? Because they believe human growth hormone can reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, boost energy, rev up sex drive, and make you look and feel decades — not years, but DECADES — younger.

11 Jun 2013

Connecticut passes law that bans minors from using indoor tanning devices

Connecticut has sent a strong message to young people that indoor tanning salons can be dangerous to their health by passing a law that bans minors under the age of 17 years old from using indoor tanning devices. The law is based on significant scientific evidence that links indoor tanning to increased risk of developing melanoma and other forms of skin cancer.

11 Jun 2013

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life issues that need to be addressed. Some of these issues include depression, fatigue, nausea and change of appearance.

11 Jun 2013

Discovery highlights protective role of liver enzyme in treating jaundice

Helping to protect newborns and older patients against more severe effects of jaundice is the hope of University of Guelph researchers, who have shown how a liver enzyme protects cells from damage caused by the condition.

10 Jun 2013

Skin News and Research

NACC recommendations address established pain therapies and preview potential future advances

PRISM Pharma announces closing of $15 million Series C financing

Chemotherapy devices: an interview with Damien Salauze, head of Curie-Cancer

More pleasant method for measuring blood pressure

New study shows treatment with brodalumab demonstrates clinical response in subjects with PsA

Tips for preventing skin cancer

Tumor suppressor p53 inactivation and restoration: an interview with Dr. Xin Lu, Ludwig Institute for Cancer Research

Neuromodulators provide guidelines for implantation of "digital drugs" to manage chronic pain

Mentor announces availability of CPX4 Tissue Expander in EMEA markets

Hebrew University student develops drug formulations to treat illnesses through skin applications

TSRI scientists identify key triggers of cancer-blocking mechanism in cells

Telemedicine: A way to decrease patient wait times in ED

Studies demonstrate that combined therapy could destroy drug-resistant cells within melanoma tumor

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Brain circuits involved in compulsive behavior reveal a surprising connection with obesity

OncoSec Medical signs Sponsored Research Agreement with ODU for melanoma study

New study explores effects of growth hormone on the skin

Connecticut passes law that bans minors from using indoor tanning devices

Chronic myeloid leukemia patients treated with tyrosine kinase inhibitors have quality-of-life issues

Discovery highlights protective role of liver enzyme in treating jaundice

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News